Collaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, ...
20 hours ago
0
12
Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? The Conversation's experts explore their rise, impact and potential consequences.
Apr 16, 2024
0
0
Adult cardiovascular care centered on the patient can improve individuals' experiences and their medical outcomes, according to a new American Heart Association Scientific Statement published today in Circulation.
Apr 11, 2024
0
0
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at ...
Apr 8, 2024
0
0
People with high blood pressure saw their systolic blood pressure drop by 7 mmHg, on average, and experienced improvements in other markers of blood vessel health after receiving daily smartphone messages designed to cultivate ...
Apr 8, 2024
0
0
A new study has revealed a popular, holistic approach to managing an individual's relationship with food and dieting has one clear benefit—reducing hunger. The Health at Every Size (HAES) practice concentrates on intuitive ...
Apr 3, 2024
0
0
Diabetic nephropathy, also called diabetic kidney disease, is a serious complication of type 1 diabetes and type 2 diabetes. In the U.S., about 1 in 3 people living with diabetes have diabetic nephropathy.
Mar 29, 2024
0
0
An expert panel has published the first performance measures to identify remission and evaluate the effectiveness of lifestyle medicine treatments, which will allow more objective comparisons between lifestyle behavior interventions ...
Mar 28, 2024
0
0
Billy Abbott, a retired Army medic, wakes at 6 every morning, steps on the bathroom scale, and uses a cuff to take his blood pressure.
Mar 28, 2024
0
0
Using patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for moderate-to-severe kidney injury after receiving the chemotherapy drug cisplatin in the largest, ...
Mar 27, 2024
0
0
